- Home
- SPLP vs BCAX Comparison
SPLP vs BCAX Comparison
Compare SPLP & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPLP
- BCAX
- Stock Information
- Founded
- SPLP 1990
- BCAX 2018
- Country
- SPLP United States
- BCAX United States
- Employees
- SPLP N/A
- BCAX N/A
- Industry
- SPLP Industrial Specialties
- BCAX
- Sector
- SPLP Industrials
- BCAX
- Exchange
- SPLP Nasdaq
- BCAX NYSE
- Market Cap
- SPLP 771.3M
- BCAX 733.5M
- IPO Year
- SPLP N/A
- BCAX 2024
- Fundamental
- Price
- SPLP $41.69
- BCAX $13.00
- Analyst Decision
- SPLP
- BCAX Strong Buy
- Analyst Count
- SPLP 0
- BCAX 6
- Target Price
- SPLP N/A
- BCAX $39.50
- AVG Volume (30 Days)
- SPLP 784.0
- BCAX 321.6K
- Earning Date
- SPLP 03-07-2025
- BCAX 03-04-2025
- Dividend Yield
- SPLP N/A
- BCAX N/A
- EPS Growth
- SPLP 28.01
- BCAX N/A
- EPS
- SPLP 9.74
- BCAX N/A
- Revenue
- SPLP $1,996,835,000.00
- BCAX N/A
- Revenue This Year
- SPLP N/A
- BCAX N/A
- Revenue Next Year
- SPLP N/A
- BCAX N/A
- P/E Ratio
- SPLP $4.34
- BCAX N/A
- Revenue Growth
- SPLP 7.29
- BCAX N/A
- 52 Week Low
- SPLP $34.55
- BCAX $11.10
- 52 Week High
- SPLP $48.45
- BCAX $28.09
- Technical
- Relative Strength Index (RSI)
- SPLP 51.86
- BCAX N/A
- Support Level
- SPLP $41.53
- BCAX N/A
- Resistance Level
- SPLP $42.25
- BCAX N/A
- Average True Range (ATR)
- SPLP 0.36
- BCAX 0.00
- MACD
- SPLP 0.18
- BCAX 0.00
- Stochastic Oscillator
- SPLP 56.94
- BCAX 0.00
About SPLP Steel Partners Holdings LP LTD PARTNERSHIP UNIT
Steel Partners Holdings LP operates in industrial products, energy, defense, supply chain management and logistics, banking, and youth sports industries. It operates in various segments including the Diversified Industrial segment comprised of manufacturers of engineered niche industrial products, including joining materials, tubing, building materials, performance materials, electrical products, cutting replacement products and services, and metallized films and packaging businesses; the Energy segment provides drilling and production services to the oil and gas industry and owns a youth sports business; the Financial Services segment consists of the operations of WebBank, a Utah chartered industrial bank, which engages in full range of banking activities.
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.